Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:603456'
s Net Margin % Range Over the Past 10 Years
Min: 6.74 Med: 12.52 Max: 18.71
Current: 12.49
SHSE:603456's Net Margin % is ranked better than 72.56% of 962
companies
in the Drug Manufacturers industry
Industry Median: 5.37
vs SHSE:603456: 12.49
Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Zhejiang Jiuzhou Pharmaceutical Co Net Margin % Related Terms
Zhejiang Jiuzhou Pharmaceutical Co Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Jiuzhou Pharmaceutical Co Net Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Jiuzhou Pharmaceutical Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Jiuzhou Pharmaceutical Co Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhejiang Jiuzhou Pharmaceutical Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Zhejiang Jiuzhou Pharmaceutical Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) has a Net Margin % of 15.66% as of Jun. 2026. Net margin is the ratio of total net income to net sales. View historical data on Zhejiang Jiuzhou Pharmaceutical Co and its competitors. This is 25% above median its historical median of 12.52. Over the past decade, Zhejiang Jiuzhou Pharmaceutical Co's Net Margin % has ranged from 6.74 to 18.71. According to the industry distribution chart, Zhejiang Jiuzhou Pharmaceutical Co ranks #264 out of 962 companies in the Drug Manufacturers industry, placing it in the top 27.4%.
Is Zhejiang Jiuzhou Pharmaceutical Co's Net Margin % too high?
Zhejiang Jiuzhou Pharmaceutical Co's current Net Margin % of 15.66% is 25% above median its 10-year median of 12.52. Over the past 10 years, this metric has ranged from a low of 6.74 to a high of 18.71. The Drug Manufacturers industry median Net Margin % is 5.37. Zhejiang Jiuzhou Pharmaceutical Co's value of 15.66% is 191.6% above this industry median. Based on the distribution chart, Zhejiang Jiuzhou Pharmaceutical Co ranks #264 out of 962 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Zhejiang Jiuzhou Pharmaceutical Co has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Jiuzhou Pharmaceutical Co's Net Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Zhejiang Jiuzhou Pharmaceutical Co ranks #264 out of 962 companies for Net Margin %. This puts Zhejiang Jiuzhou Pharmaceutical Co in the upper half of its industry. The industry median Net Margin % is 5.37. Zhejiang Jiuzhou Pharmaceutical Co's value of 15.66% is 191.6% above this benchmark. Historically, Zhejiang Jiuzhou Pharmaceutical Co's own Net Margin % has ranged from 6.74 to 18.71 over the past decade. While the company's 10-year median is 12.52 vs. the industry median of 5.37, Zhejiang Jiuzhou Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.37, based on 962 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Jiuzhou Pharmaceutical Co's current Net Margin % of 15.66% is 191.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Zhejiang Jiuzhou Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Jiuzhou Pharmaceutical Co's current Net Margin % is 15.66%, which is 25% above median its own 10-year median of 12.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Jiuzhou Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) is currently considered Fairly Valued. The stock's GF Value™ is ¥16.96, compared to a current price of ¥15.46 — trading 8.8% below its estimated fair value. The current Net Margin % is 15.66%, which is 25% above median its 10-year median of 12.52 and 191.6% above the Drug Manufacturers industry median of 5.37. Zhejiang Jiuzhou Pharmaceutical Co's overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456), the current Net Margin % is 15.66% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Jiuzhou Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥15.46 is trading 8.8% below its estimated GF Value™ of ¥16.96.
GuruFocus considers Zhejiang Jiuzhou Pharmaceutical Co to be Fairly Valued.
Key valuation signals for SHSE:603456:
Net Margin %: 15.66% (25% above median its 10-year median of 12.52)
GF Value™: ¥16.96 vs. price of ¥15.46 (8.8% below fair value)
Industry Position: 191.6% above the Drug Manufacturers median (#264 of 962)
No single metric tells the full story. See the SHSE:603456 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhejiang Jiuzhou Pharmaceutical Co Ltd is a China-based pharmaceutical manufacturer. The company is primarily engaged in the manufacturing, research, development, and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst, and lithium battery materials. Its active pharmaceutical ingredient offerings include Carbamazepine, Duloxetine, Bezafibrate, Meropenem, Sulphadimethoxine Sodium, Oxcarbazepine, and Amprolium, among others. The firm also provides services of new drug contract development and manufacturing organization to the international pharmaceutical giant.
95GF Score
Get the complete analysis for SHSE:603456
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603456 has been successfully added to your 
